Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07198009) titled '2-HOBA Supplementation in People With Elevated Lipoprotein(a)' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: The Miriam Hospital
Condition:
Hyperlipidemia
Elevated Lp(a)
Intervention:
Dietary Supplement: 2-HOBA (Hobamine)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2025
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07198009
Published by HT Digit...